Giripladib

Drug Profile

Giripladib

Alternative Names: PLA-695

Latest Information Update: 05 Oct 2011

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Wyeth
  • Class Analgesics; Antirheumatics; Benzoic acids
  • Mechanism of Action Phospholipase A2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Rheumatoid arthritis

Most Recent Events

  • 14 Jun 2008 Preclinical pharmacodynamics data in Rheumatoid arhtritis presented at the Annual European Congress of Rheumatology (EULAR-2008)
  • 31 Dec 2006 Phase-I clinical trials in Rheumatoid arthritis in USA (PO)
  • 31 Dec 2006 Phase-I clinical trials in Rheumatoid arthritis in Canada (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top